Intrinsic value of Teladoc - TDOC

Previous Close

$33.25

  Intrinsic Value

$0.19

stock screener

  Rating & Target

str. sell

-99%

Previous close

$33.25

 
Intrinsic value

$0.19

 
Up/down potential

-99%

 
Rating

str. sell

We calculate the intrinsic value of TDOC stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 2016), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 1.9

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
2016(a)
   2017
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  59.74
  60.00
  54.50
  49.55
  45.10
  41.09
  37.48
  34.23
  31.31
  28.68
  26.31
  24.18
  22.26
  20.53
  18.98
  17.58
  16.32
  15.19
  14.17
  13.26
  12.43
  11.69
  11.02
  10.42
  9.87
  9.39
  8.95
  8.55
  8.20
  7.88
  7.59
Revenue, $m
  123
  197
  304
  455
  660
  931
  1,280
  1,718
  2,255
  2,902
  3,666
  4,552
  5,565
  6,708
  7,981
  9,385
  10,917
  12,575
  14,357
  16,260
  18,281
  20,418
  22,667
  25,028
  27,500
  30,081
  32,773
  35,576
  38,493
  41,526
  44,678
Variable operating expenses, $m
 
  249
  375
  552
  792
  1,110
  1,519
  2,032
  2,663
  3,421
  4,316
  5,336
  6,523
  7,863
  9,355
  11,000
  12,796
  14,740
  16,829
  19,059
  21,428
  23,933
  26,570
  29,337
  32,234
  35,260
  38,415
  41,701
  45,120
  48,675
  52,369
Fixed operating expenses, $m
 
  33
  34
  34
  35
  36
  37
  38
  39
  40
  41
  42
  43
  44
  45
  46
  48
  49
  50
  51
  52
  54
  55
  56
  58
  59
  61
  62
  64
  65
  67
Total operating expenses, $m
  194
  282
  409
  586
  827
  1,146
  1,556
  2,070
  2,702
  3,461
  4,357
  5,378
  6,566
  7,907
  9,400
  11,046
  12,844
  14,789
  16,879
  19,110
  21,480
  23,987
  26,625
  29,393
  32,292
  35,319
  38,476
  41,763
  45,184
  48,740
  52,436
Operating income, $m
  -71
  -85
  -105
  -132
  -168
  -215
  -276
  -353
  -446
  -558
  -691
  -826
  -1,001
  -1,199
  -1,419
  -1,662
  -1,927
  -2,214
  -2,522
  -2,850
  -3,200
  -3,569
  -3,957
  -4,365
  -4,792
  -5,238
  -5,703
  -6,187
  -6,691
  -7,214
  -7,759
EBITDA, $m
  -63
  -64
  -82
  -107
  -141
  -185
  -242
  -313
  -401
  -505
  -629
  -772
  -935
  -1,120
  -1,325
  -1,551
  -1,798
  -2,065
  -2,352
  -2,658
  -2,983
  -3,327
  -3,689
  -4,069
  -4,467
  -4,882
  -5,315
  -5,766
  -6,235
  -6,723
  -7,230
Interest expense (income), $m
  2
  2
  5
  8
  13
  20
  28
  40
  54
  71
  92
  117
  145
  178
  215
  256
  301
  351
  404
  462
  523
  588
  657
  730
  806
  886
  969
  1,056
  1,147
  1,241
  1,339
Earnings before tax, $m
  -74
  -88
  -109
  -140
  -181
  -235
  -305
  -392
  -500
  -630
  -783
  -942
  -1,146
  -1,377
  -1,634
  -1,918
  -2,228
  -2,564
  -2,926
  -3,312
  -3,723
  -4,157
  -4,615
  -5,095
  -5,598
  -6,124
  -6,672
  -7,243
  -7,837
  -8,455
  -9,097
Tax expense, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Net income, $m
  -74
  -88
  -109
  -140
  -181
  -235
  -305
  -392
  -500
  -630
  -783
  -942
  -1,146
  -1,377
  -1,634
  -1,918
  -2,228
  -2,564
  -2,926
  -3,312
  -3,723
  -4,157
  -4,615
  -5,095
  -5,598
  -6,124
  -6,672
  -7,243
  -7,837
  -8,455
  -9,097

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  66
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  304
  381
  588
  880
  1,276
  1,800
  2,475
  3,322
  4,363
  5,614
  7,090
  8,805
  10,765
  12,975
  15,438
  18,152
  21,115
  24,323
  27,770
  31,451
  35,360
  39,493
  43,844
  48,411
  53,191
  58,185
  63,391
  68,813
  74,455
  80,321
  86,417
Adjusted assets (=assets-cash), $m
  238
  381
  588
  880
  1,276
  1,800
  2,475
  3,322
  4,363
  5,614
  7,090
  8,805
  10,765
  12,975
  15,438
  18,152
  21,115
  24,323
  27,770
  31,451
  35,360
  39,493
  43,844
  48,411
  53,191
  58,185
  63,391
  68,813
  74,455
  80,321
  86,417
Revenue / Adjusted assets
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
Average production assets, $m
  27
  43
  67
  100
  145
  205
  282
  378
  496
  638
  806
  1,001
  1,224
  1,476
  1,756
  2,065
  2,402
  2,766
  3,159
  3,577
  4,022
  4,492
  4,987
  5,506
  6,050
  6,618
  7,210
  7,827
  8,468
  9,136
  9,829
Working capital, $m
  62
  -3
  -5
  -7
  -11
  -15
  -20
  -27
  -36
  -46
  -59
  -73
  -89
  -107
  -128
  -150
  -175
  -201
  -230
  -260
  -293
  -327
  -363
  -400
  -440
  -481
  -524
  -569
  -616
  -664
  -715
Total debt, $m
  44
  84
  146
  233
  351
  508
  709
  961
  1,271
  1,644
  2,084
  2,595
  3,179
  3,838
  4,571
  5,380
  6,263
  7,219
  8,246
  9,343
  10,508
  11,740
  13,037
  14,397
  15,822
  17,310
  18,862
  20,477
  22,159
  23,907
  25,723
Total liabilities, $m
  73
  113
  175
  262
  380
  537
  738
  990
  1,300
  1,673
  2,113
  2,624
  3,208
  3,867
  4,600
  5,409
  6,292
  7,248
  8,275
  9,372
  10,537
  11,769
  13,066
  14,426
  15,851
  17,339
  18,891
  20,506
  22,188
  23,936
  25,752
Total equity, $m
  231
  267
  413
  617
  896
  1,264
  1,738
  2,332
  3,063
  3,941
  4,978
  6,181
  7,557
  9,108
  10,837
  12,743
  14,823
  17,075
  19,495
  22,079
  24,823
  27,724
  30,779
  33,984
  37,340
  40,846
  44,501
  48,307
  52,267
  56,385
  60,665
Total liabilities and equity, $m
  304
  380
  588
  879
  1,276
  1,801
  2,476
  3,322
  4,363
  5,614
  7,091
  8,805
  10,765
  12,975
  15,437
  18,152
  21,115
  24,323
  27,770
  31,451
  35,360
  39,493
  43,845
  48,410
  53,191
  58,185
  63,392
  68,813
  74,455
  80,321
  86,417
Debt-to-equity ratio
  0.190
  0.320
  0.350
  0.380
  0.390
  0.400
  0.410
  0.410
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
Adjusted equity ratio
  0.693
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  -74
  -88
  -109
  -140
  -181
  -235
  -305
  -392
  -500
  -630
  -783
  -942
  -1,146
  -1,377
  -1,634
  -1,918
  -2,228
  -2,564
  -2,926
  -3,312
  -3,723
  -4,157
  -4,615
  -5,095
  -5,598
  -6,124
  -6,672
  -7,243
  -7,837
  -8,455
  -9,097
Depreciation, amort., depletion, $m
  8
  21
  22
  24
  27
  30
  34
  39
  45
  53
  62
  54
  66
  79
  94
  111
  129
  149
  170
  192
  216
  242
  268
  296
  325
  356
  388
  421
  455
  491
  528
Funds from operations, $m
  -56
  -67
  -87
  -116
  -154
  -205
  -271
  -353
  -454
  -576
  -721
  -889
  -1,081
  -1,298
  -1,540
  -1,807
  -2,099
  -2,416
  -2,756
  -3,120
  -3,507
  -3,916
  -4,347
  -4,799
  -5,273
  -5,768
  -6,285
  -6,822
  -7,382
  -7,964
  -8,569
Change in working capital, $m
  -4
  -1
  -2
  -2
  -3
  -4
  -6
  -7
  -9
  -10
  -12
  -14
  -16
  -18
  -20
  -22
  -25
  -27
  -29
  -30
  -32
  -34
  -36
  -38
  -40
  -41
  -43
  -45
  -47
  -49
  -50
Cash from operations, $m
  -52
  -66
  -85
  -113
  -151
  -201
  -265
  -346
  -446
  -566
  -709
  -874
  -1,064
  -1,279
  -1,519
  -1,784
  -2,074
  -2,389
  -2,727
  -3,089
  -3,474
  -3,882
  -4,311
  -4,761
  -5,234
  -5,727
  -6,242
  -6,778
  -7,335
  -7,916
  -8,518
Maintenance CAPEX, $m
  0
  -1
  -2
  -4
  -5
  -8
  -11
  -15
  -20
  -27
  -34
  -43
  -54
  -66
  -79
  -94
  -111
  -129
  -149
  -170
  -192
  -216
  -242
  -268
  -296
  -325
  -356
  -388
  -421
  -455
  -491
New CAPEX, $m
  -3
  -16
  -24
  -33
  -45
  -60
  -77
  -96
  -118
  -142
  -168
  -195
  -223
  -251
  -280
  -309
  -337
  -365
  -392
  -419
  -445
  -470
  -495
  -519
  -544
  -568
  -592
  -617
  -642
  -667
  -693
Cash from investing activities, $m
  26
  -17
  -26
  -37
  -50
  -68
  -88
  -111
  -138
  -169
  -202
  -238
  -277
  -317
  -359
  -403
  -448
  -494
  -541
  -589
  -637
  -686
  -737
  -787
  -840
  -893
  -948
  -1,005
  -1,063
  -1,122
  -1,184
Free cash flow, $m
  -26
  -83
  -111
  -150
  -201
  -268
  -353
  -458
  -584
  -735
  -911
  -1,113
  -1,341
  -1,597
  -1,879
  -2,188
  -2,523
  -2,883
  -3,268
  -3,678
  -4,111
  -4,568
  -5,047
  -5,549
  -6,073
  -6,620
  -7,190
  -7,782
  -8,398
  -9,038
  -9,703
Issuance/(repayment) of debt, $m
  18
  42
  62
  87
  118
  156
  201
  252
  310
  373
  440
  511
  584
  659
  734
  809
  883
  956
  1,027
  1,097
  1,165
  1,231
  1,297
  1,361
  1,425
  1,488
  1,552
  1,616
  1,681
  1,748
  1,817
Issuance/(repurchase) of shares, $m
  3
  188
  255
  344
  459
  603
  778
  987
  1,230
  1,508
  1,820
  2,146
  2,522
  2,929
  3,363
  3,823
  4,308
  4,816
  5,346
  5,896
  6,467
  7,058
  7,669
  8,301
  8,954
  9,629
  10,327
  11,050
  11,798
  12,573
  13,377
Cash from financing (excl. dividends), $m  
  21
  230
  317
  431
  577
  759
  979
  1,239
  1,540
  1,881
  2,260
  2,657
  3,106
  3,588
  4,097
  4,632
  5,191
  5,772
  6,373
  6,993
  7,632
  8,289
  8,966
  9,662
  10,379
  11,117
  11,879
  12,666
  13,479
  14,321
  15,194
Total cash flow (excl. dividends), $m
  -5
  147
  206
  281
  376
  491
  627
  782
  956
  1,146
  1,349
  1,544
  1,765
  1,991
  2,218
  2,445
  2,669
  2,889
  3,105
  3,315
  3,521
  3,722
  3,919
  4,113
  4,305
  4,497
  4,689
  4,884
  5,081
  5,283
  5,491
Retained Cash Flow (-), $m
  -52
  -188
  -255
  -344
  -459
  -603
  -778
  -987
  -1,230
  -1,508
  -1,820
  -2,146
  -2,522
  -2,929
  -3,363
  -3,823
  -4,308
  -4,816
  -5,346
  -5,896
  -6,467
  -7,058
  -7,669
  -8,301
  -8,954
  -9,629
  -10,327
  -11,050
  -11,798
  -12,573
  -13,377
Prev. year cash balance distribution, $m
 
  64
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
 
  23
  -49
  -63
  -83
  -112
  -152
  -205
  -274
  -362
  -471
  -602
  -757
  -938
  -1,145
  -1,379
  -1,640
  -1,927
  -2,241
  -2,581
  -2,946
  -3,336
  -3,750
  -4,188
  -4,649
  -5,132
  -5,638
  -6,166
  -6,717
  -7,290
  -7,886
Discount rate, %
 
  4.30
  4.52
  4.74
  4.98
  5.23
  5.49
  5.76
  6.05
  6.35
  6.67
  7.00
  7.35
  7.72
  8.11
  8.51
  8.94
  9.39
  9.86
  10.35
  10.87
  11.41
  11.98
  12.58
  13.21
  13.87
  14.56
  15.29
  16.05
  16.86
  17.70
PV of cash for distribution, $m
 
  22
  -45
  -55
  -68
  -87
  -110
  -139
  -172
  -208
  -247
  -286
  -323
  -357
  -384
  -405
  -417
  -419
  -413
  -397
  -374
  -345
  -311
  -274
  -237
  -200
  -164
  -132
  -104
  -80
  -59
Current shareholders' claim on cash, %
  100
  87.9
  78.7
  71.4
  65.4
  60.4
  56.2
  52.5
  49.3
  46.5
  44.0
  41.8
  39.8
  38.0
  36.4
  34.8
  33.5
  32.2
  31.0
  29.9
  28.8
  27.9
  27.0
  26.1
  25.3
  24.5
  23.8
  23.1
  22.4
  21.8
  21.1

Teladoc, Inc. is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company's solution connects its Members, with its over 3,000 board certified physicians and behavioral health professionals treating a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation. As of July 17, 2017, it served over 7,500 employers, health plans, health systems and other entities. As of July 17, 2017, these clients collectively purchased access to its solution for more than 20 million Members. As of December 31, 2016, it had over 30 health plans as Clients. Its solutions consist of an integrated technology platform, Provider network, consumer engagement strategies and entrenched distribution channels.

FINANCIAL RATIOS  of  Teladoc (TDOC)

Valuation Ratios
P/E Ratio -20.8
Price to Sales 12.5
Price to Book 6.7
Price to Tangible Book
Price to Cash Flow -29.5
Price to Free Cash Flow -27.9
Growth Rates
Sales Growth Rate 59.7%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate -62.5%
Cap. Spend. - 3 Yr. Gr. Rate 24.6%
Financial Strength
Quick Ratio 33
Current Ratio 0
LT Debt to Equity 18.2%
Total Debt to Equity 19%
Interest Coverage -36
Management Effectiveness
Return On Assets -27%
Ret/ On Assets - 3 Yr. Avg. -29.5%
Return On Total Capital -30.8%
Ret/ On T. Cap. - 3 Yr. Avg. -35%
Return On Equity -36.1%
Return On Equity - 3 Yr. Avg. -44.4%
Asset Turnover 0.5
Profitability Ratios
Gross Margin 74%
Gross Margin - 3 Yr. Avg. 74.7%
EBITDA Margin -52%
EBITDA Margin - 3 Yr. Avg. -50%
Operating Margin -57.7%
Oper. Margin - 3 Yr. Avg. -54.8%
Pre-Tax Margin -60.2%
Pre-Tax Margin - 3 Yr. Avg. -58%
Net Profit Margin -60.2%
Net Profit Margin - 3 Yr. Avg. -58%
Effective Tax Rate 0%
Eff/ Tax Rate - 3 Yr. Avg. 0%
Payout Ratio 0%

TDOC stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the TDOC stock intrinsic value calculation we used $123 million for the last fiscal year's total revenue generated by Teladoc. The default revenue input number comes from 2016 income statement of Teladoc. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our TDOC stock valuation model: a) initial revenue growth rate of 60% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 4.3%, whose default value for TDOC is calculated based on our internal credit rating of Teladoc, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Teladoc.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of TDOC stock the variable cost ratio is equal to 132.5%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $32 million in the base year in the intrinsic value calculation for TDOC stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 5.6% for Teladoc.

Corporate tax rate of 27% is the nominal tax rate for Teladoc. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the TDOC stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for TDOC are equal to 22%.

Life of production assets of 18.6 years is the average useful life of capital assets used in Teladoc operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for TDOC is equal to -1.6%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $231 million for Teladoc - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 56.642 million for Teladoc is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Teladoc at the current share price and the inputted number of shares is $1.9 billion.

RELATED COMPANIES Price Int.Val. Rating

COMPANY NEWS

▶ Teladoc Scores Relative Strength Rating Upgrade   [Dec-08-17 03:00AM  Investor's Business Daily]
▶ Teladoc Announces Pricing of Sale of Shares of Common Stock   [Nov-29-17 06:19PM  GlobeNewswire]
▶ Can Teladoc Stock Keep Going After Last Week's 24% Pop?   [Nov-26-17 12:11PM  Motley Fool]
▶ Teladoc, Inc. (TDOC) Jumps: Stock Rises 10.5%   [Nov-22-17 08:43AM  Zacks]
▶ ETFs with exposure to Teladoc, Inc. : November 17, 2017   [Nov-17-17 01:01PM  Capital Cube]
▶ ETFs with exposure to Teladoc, Inc. : November 6, 2017   [Nov-06-17 12:33PM  Capital Cube]
▶ Teladoc reports 3Q loss   [Nov-01-17 05:21PM  Associated Press]
▶ Teladoc Announces Third Quarter 2017 Results   [04:01PM  GlobeNewswire]
▶ Teladoc, Inc. to Host Earnings Call   [12:20PM  ACCESSWIRE]
▶ ETFs with exposure to Teladoc, Inc. : October 25, 2017   [Oct-25-17 10:13AM  Capital Cube]
▶ The 3 Stocks on the MFM Team's Radar This Week   [Oct-19-17 02:05PM  Motley Fool]
▶ Four Biotech And Health Care Breakouts   [Oct-18-17 12:52PM  Forbes]
▶ Teladoc to Announce Third Quarter 2017 Financial Results   [Oct-17-17 08:35AM  GlobeNewswire]
▶ ETFs with exposure to Teladoc, Inc. : October 13, 2017   [Oct-13-17 11:17AM  Capital Cube]
▶ Teladoc to Unveil New Mobile App Experience at Health 2.0   [Oct-03-17 08:35AM  GlobeNewswire]
▶ ETFs with exposure to Teladoc, Inc. : October 2, 2017   [Oct-02-17 11:07AM  Capital Cube]
▶ Teladoc Adds David Schloss as Chief Human Resources Officer   [Aug-21-17 09:40AM  GlobeNewswire]
▶ Teladoc to Participate in Upcoming Investor Conferences   [Aug-16-17 08:25AM  GlobeNewswire]
▶ Teladoc reports 2Q loss   [12:25AM  Associated Press]
▶ Teladoc Announces Second Quarter 2017 Results   [Aug-02-17 04:01PM  GlobeNewswire]
▶ Teladoc to Participate in Upcoming Investor Conferences   [Aug-01-17 04:21PM  GlobeNewswire]
▶ 3 Stocks Your Children Will Brag About Someday   [Jul-21-17 06:00AM  Motley Fool]
▶ Teladoc Completes Acquisition of Best Doctors   [Jul-17-17 08:25AM  GlobeNewswire]
▶ 3 of 2017's Fastest Growing Companies   [Jul-12-17 12:06PM  Motley Fool]
▶ Teladoc to Announce Second Quarter 2017 Financial Results   [Jul-11-17 08:25AM  GlobeNewswire]
▶ This Company Is Disrupting Doctor's Offices   [Jul-10-17 01:41PM  Motley Fool]
▶ Parexel, Lennar rise; Teladoc, Chipotle Mexican Grill fall   [Jun-20-17 04:28PM  Associated Press]
▶ 3 Hot Small-Cap Tech Stocks   [12:25PM  Investopedia]
▶ Teladoc acquiring Boston medical consultation firm in $440M deal   [Jun-19-17 10:30PM  American City Business Journals]
▶ Harry Boxer: 4 stocks with strong technical momentum   [Jun-15-17 08:48AM  MarketWatch]
▶ ETFs with exposure to Teladoc, Inc. : June 2, 2017   [Jun-02-17 02:33PM  Capital Cube]
▶ Teladoc to Participate in Upcoming Investor Conferences   [Jun-01-17 08:30AM  GlobeNewswire]
Financial statements of TDOC
Valuation of Stocks

The paper VALUATION OF STOCKS: The Quest for Intrinsic Value provides a detailed description of our valuation model and discloses the calculation algorithm.

FREE DOWNLOAD
Follow us on:   twitter   twitter   twitter   twitter

VALUATION THEORY       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2017. All rigths reserved.